Toward a molecular understanding of nanoparticle-protein interactions

Biophysical Reviews

Volumn 4, Issue 2, 2012, Pages 137-147

  Treuel, Lennart ^a,b   Nienhaus, Gerd Ulrich ^a,c  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c University of Illinois at Urbana Champaign   (United States)

Author keywords

Nanoparticle imaging; Nanoparticle spectroscopy; Nanoparticle toxicity; Nanoparticle protein interactions; Nanoparticles; Protein corona

Indexed keywords

EID: 84864741149     PISSN: 18672450     EISSN: 18672469     Source Type: Journal    
DOI: 10.1007/s12551-012-0072-0     Document Type: Review

References (97)

1. 2 nanoparticles for radiotracer studies. J Nanopart Res 12: 2435-2443.
2. Aitken RJ, Chaudhry MQ, Boxall ABA, Hull M (2006) Manufacture and use of nanomaterials: current status in the UK and global trends. Occup Med 56: 300-306.
3. Anselmann R (2001) Nanoparticles and nanolayers in commercial applications. J Nanopart Res 3: 329-336.
4. Asha Rani PV, Low Kah Mun G, Hande MP, Valiyaveettil S (2008) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3(2): 279-290.
5. Aubin-Tam M-E, Hamad-Schifferli K (2005) Gold nanoparticle-cytochrome c complexes: the effect of nanoparticle ligand charge on protein structure. Langmuir 21: 12080-12084.
6. Baier G, Costa C, Zeller A, Baumann D, Sayer C, Araujo PHH, Mailänder V, Musyanovych A, Landfester K (2011) BSA adsorption on differently charged polystyrene nanoparticles using isothermal titration calorimetry and the influence on cellular uptake. Macromol Biosci 11: 628-638.
7. Barnard AS (2006) Nanohazards: knowledge is our first defence. Nat Mater 5(4): 245-248.
8. Baron MH, Revault M, Servagent-Noinville S, Abadie J, Qui-Quampoix HJ (1999) Chymotrypsin adsorption on montmorillonite: enzymatic activity and kinetic FTIR structural analysis. J Coll Interf Sci 214: 319-332.
9. Brandes N, Welzel PB, Werner C, Kroh LW (2006) Adsorption-induced conformational changes of proteins onto ceramic particles: differential scanning calorimetry and FTIR analysis. J Coll Interf Sci 299: 56-69.
10. Carpenter JF, Randolph TW, Jiskoot W, Crommelin DJA, Middaugh CR, Winter G (2010) Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products. J Pharmaceut Sci 99(5): 2200-2208.
11. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V (2010) Time evolution of the nanoparticle protein corona. ACS Nano 4(7): 3623-3632.
12. 2) nanoparticles. Small 7(24): 3479-3486.
13. Cedervall T, Lynch I, Foy M, Berggård T, Donnelly SC, Cagney G, Linse S, Dawson KA (2007a) Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed 46: 5754-5756.
14. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson KA, Linse S (2007b) Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104(7): 2050-2055.
15. Cheng Y, Wang M, Borghs G, Chen H (2011) Gold nanoparticle dimers for plasmon sensing. Langmuir 27: 7884-7891.
16. Chithrani BD, Chan WCW (2007) Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7(6): 1542-1550.
17. Chittur KK (1998) FTIR/ATR for protein adsorption to biomaterial surfaces. Biomaterials 19(4-5): 357-369.
18. De Paoli Lacerda SH, Park JJ, Meuse C, Pristinski D, Becker ML, Karim A, Douglas JF (2010) Interaction of gold nanoparticles with common human blood proteins. ACS Nano 4(1): 365-379.
19. Des Rieux A, Fievez V, Garinot M, Schneider Y-J, Préat V (2006) Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116: 1-27.
20. Ehrenberg MS, Friedman AE, Finkelstein JN, Oberdörster G, McGrath JL (2009) The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 30(4): 603-610.
21. Fillafer C, Friedl DS, Ilyes AK, Wirth M, Gabor F (2009) Bionanoprobes to study particle-cell interactions. J Nanosci Nanotechnol 9: 3239-3245.
22. Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P (2005) Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113(11): 1555-1560.
23. Gilbert B, Huang F, Zhang H, Waychunas GA, Banfield JF (2004) Nanoparticles: strained and stiff. Science 305(5684): 651-654.
24. Goodman CM, McCusker CD, Yilmaz T, Rotello VM (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15: 897-900.
25. Greenfield NJ (1999) Applications of circular dichroism in protein and peptide analysis. Trends Anal Chem 18(4): 236-244.
26. Greulich C, Kittler S, Epple M, Muhr G, Köller M (2009) Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg 394: 495-502.
27. Handy RD, Henry TB, Scrown TM, Johnston BD, Tyler CR (2008a) Manufactured nanoparticles: their uptake and effects on fish-a mechanistic analysis. Ecotoxicology 17(5): 396-409.
28. Handy RD, von der Kammer F, Lead JR, Hassellöv M, Owen R, Crane M (2008b) The ecotoxicology and chemistry of manufactured nanoparticles. Ecotoxicology 17: 287-314.
29. Harris JM, Martin NE, Modi M (2001) Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet 40: 539-551.
30. Havel HA (1996) Spectroscopic methods for determining protein structure in solution. Wiley-VCH, New York.
31. Jeong SK, Kwon MS, Lee EY, Lee HJ, Cho SY, Kim H, Yoo JS, Omenn GS, Aebersold R, Hanash S, Paik YK (2009) BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers. Proteomics 9(14): 3729-3740.
32. Jiang X, Weise S, Hafner M, Röcker C, Zhang F, Parak WJ, Nienhaus GU (2010) Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding. J R Soc Interface 7: S5-S13.
33. Kah JC, Wong KY, Neoh KG, Song JH, Fu JW, Mhaisalkar S, Olivo M, Sheppard CJ (2009) Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J Drug Target 17: 181-193.
34. Keller KH (2007) Nanotechnology and society. J Nanopart Res 9: 5-10.
35. Kelly SM, Jess TJ, Price NC (2005) How to study proteins by circular dichroism. Biochim Biophys Acta 1751: 119-139.
36. Kittler S, Greulich C, Diendorf J, Köller M, Epple M (2010a) The toxicity of silver nanoparticles increases during storage due to slow dissolution under release of silver ions. Chem Mater 22(16): 4548-4554.
37. Kittler S, Greulich C, Gebauer JS, Diendorf J, Treuel L, Ruiz L, Gonzalez-Calbet JM, Vallet-Regi M, Zellner R, Köller M, Epple M (2010b) The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles. J Mater Chem 20(3): 512-518.
38. Klein J (2007) Probing the interactions of proteins and nanoparticles. Proc Natl Acad Sci USA 104(7): 2029-2030.
39. Kreyling WG, Semmler M, Möller W (2004) Dosimetry and toxicology of ultrafine particles. J Aerosol Med 17(2): 140-152.
40. Leszczynski J (2010) Bionanoscience: nano meets bio at the interface. Nat Nanotechnol 5(9): 633-634.
41. Linse S, Cabaleiro-Lago C, Xue W-F, Lynch I, Lindman S, Thulin E, Radford SE, Dawson KA (2007) Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci USA 104(21): 8691-8696.
42. Liu L, Xu K, Wang H, Tan PKJ, Fan W, Venkatraman SS, Li L, Yang Y-Y (2009) Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nat Nanotechnol 4: 457-463.
43. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105(38): 14265-14270.
44. Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan MB, Lynch I, Elia G, Dawson K (2011) The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5(9): 7503-7509.
45. Lunov O, Syrovets T, Röcker C, Tron K, Nienhaus GU, Rasche V, Mailänder V, Landfester K, Simmet T (2010) Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials 31(34): 9015-9022.
46. Lunov O, Zablotskii V, Syrovets T, Röcker C, Tron K, Nienhaus GU, Simmet T (2011) Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages. Biomaterials 32(2): 547-555.
47. Lynch I (2007) Are there generic mechanisms governing interactions between nanoparticles and cells? Random epitope mapping for the outer layer of the protein-material interface. Physica A 373: 511-520.
48. Lynch I, Dawson KA, Linse S (2006) Detecting cryptic epitopes created by nanoparticles. Sci STKE 2006(327): 14.
49. Maffre P, Nienhaus K, Amin F, Parak WJ, Nienhaus GU (2011) Characterization of protein adsorption onto FePt nanoparticles using dual-focus fluorescence correlation spectroscopy. Beilstein J Nanotechnol 2: 374-383.
50. Mátyus L, Szöllösi J, Jenei A (2006) Steady-state fluorescence quenching applications for studying protein structure and dynamics. J Photochem Photobiol B: Biol 83: 223-236.
51. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldsen K, Oberdörster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB (2006) Safe handling of nanotechnology. Nature 444: 267-269.
52. Medintz IL, Konnert JH, Clapp AR, Stanish I, Twing ME, Mattoussi H, Mauro JM, Deschamps JR (2004) A fluorescence resonance energy transfer-derived structure of a quantum dot-protein bioconjugate nanoassembly. Proc Natl Acad Sci USA 101(26): 9612-9617.
53. Min Y, Akbulut M, Kristiansen K, Golan Y, Israelachvili J (2008) The role of interparticle and external forces in nanoparticle assembly. Nat Mater 7(7): 527-538.
54. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA (2011) Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133(8): 2525-2534.
55. Mori S, Barth HG (1999) Size exclusion chromatography. Springer, Berlin.
56. Nativo P, Prior IA, Brust M (2008) Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2: 1639-1644.
57. Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311: 622-627.
58. Nel AE, Mädler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M (2009) Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8(7): 543-557.
59. Nienhaus GU (ed) (2005) Protein-ligand interactions: methods and applications. Humana Press, New York.
60. Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y (2006) PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 114: 343-347.
61. Oberdörster G (2010) Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267(1): 89-105.
62. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H (2005a) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2(8): 1-35.
63. Oberdörster G, Oberdörster E, Oberdörster J (2005b) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7): 823-839.
64. Organization for Economic Co-operation and Development (OECD) (2008) Current developments/activities on the safety of manufactured nanomaterials. OECD environment, health and safety publication series on the safety of manufactured nanomaterials. OECD, Paris.
65. Owen R, Depledge M (2005) Nanotechnology in the environment: risks and rewards. Mar Pollut Bull 50: 609-612.
66. Owens DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307: 93-102.
67. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U (2007) Size-dependent cytotoxicity of gold nanoparticles. Small 3: 1941-1949.
68. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, Stone V, Brown S, Macnee W, Donaldson K (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestoslike pathogenicity in a pilot study. Nature 3: 423-428.
69. Printz M, Friess W (2012) Simultaneous detection and analysis of protein aggregation and protein unfolding by size exclusion chromatography with post column addition of the fluorescent dye BisANS. J Pharmaceut Sci 101(2): 826-837.
70. Roach P, Farrar D, Perry CC (2006) Surface tailoring for controlled protein adsorption: effect of topography at the nanometer scale and chemistry. J Am Chem Soc 128(12): 3939-3945.
71. Röcker C, Pötzl M, Zhang F, Parak WJ, Nienhaus GU (2009) A quantitative fluoresence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol 4(9): 577-580.
72. Roco MC (2008) The journal of nanoparticle research at 10 years. J Nanopart Res 10(1): 1-2.
73. Rodriguez CE, Fukuto JM, Taguchi K, Froines J, Cho AK (2005) The interactions of 9, 10-phenantrenequinone with glyceraldehyde-3-phosphatedehydrogenase (GAPDH), a potential site for toxic actions. Chem Biol Interact 155(1): 97-110.
74. Rothen-Rutishauser B, Kiama S, Gehr P (2005) A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 32(4): 281-289.
75. Royer CA (2006) Probing protein folding and conformational transitions with fluorescence. Chem Rev 106: 1769-1784.
76. Schlücker S (2008) Gezielte Proteinlokalisierung. Biophotonik 3: 18-20.
77. Semmler-Behnke M, Takenaka S, Fertsch S, Wenk A, Seitz J, Mayer P, Oberdoerster G, Kreyling WG (2007) Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect 115(5): 728-733.
78. Service RF (2006) Priorities needed for nano-risk research and development. Science 314: 45.
79. Shang L, Wang Y, Jiang J, Dong S (2007) pH-dependent protein conformational changes in albumin-gold nanoparticle bioconjugates: a spectroscopic study. Langmuir 23: 2714-2721.
80. Shang W, Nuffer JH, Muñiz-Papandrea VA, Colón W, Siegel RW, Dordick JS (2009) cytochrome c on silica nanoparticles: influence of nanoparticle size on protein structure, stability, and activity. Small 5(4): 470-476.
81. Shang L, Brandholt S, Stockmar F, Trouillet V, Bruns M, Nienhaus GU (2011a) Effect of protein adsorption on the fluorescence of ultrasmall gold nanoclusters. Small. doi: 10. 1002/smll. 201101353.
82. Shang L, Doerlich RM, Brandholt S, Schneider R, Trouillet V, Bruns M, Gerthsen D, Nienhaus GU (2011b) Facile preparation of water-soluble fluorescent gold nanoclusters for cellular imaging applications. Nanoscale 3(5): 2009-2014.
83. Shang L, Dong S, Nienhaus GU (2011c) Ultra-small fluorescent metal nanoclusters: synthesis and biological applications. Nano Today 6(4): 401-418.
84. Shao M, Lu L, Wang H, Luo S, Duo Duo Ma D (2009) Microfabrication of a new sensor based on silver and silicon nanomaterials, and its application to the enrichment and detection of bovine serum albumin via surface-enhanced Raman scattering. Microchim Acta 164: 157-160.
85. Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, Sirirattanapan J, Mann W, Treuel L, Zellner R, Maskos M, Schild H, Stauber RH (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5(9): 7155-7167.
86. Treuel L, Malissek M, Gebauer JS, Zellner R (2010) The influence of surface composition of nanoparticles on their interactions with serum albumin. Chem Phys Chem 11(14): 3093-3099.
87. Vertegel AA, Siegel RW, Dordic JS (2004) Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir 20(16): 6800-6807.
88. Vogt A, D'Angelo C, Oswald F, Denzel A, Mazel CH, Matz MV, Ivanchenko S, Nienhaus GU, Wiedenmann J (2008) A green fluorescent protein with photoswitchable emission from the deep sea. PLoS One 3(11): 1-8.
89. Wang T, Bai J, Jiang X, Nienhaus GU (2012) Cellular uptake of nanoparticles by membrane penetration: a study combining confocal microscopy with FTIR spectroelectrochemistry. ACS Nano. doi: 10. 1021/nn203892h.
90. Watari F, Takashi N, Yokoyama A, Uo M, Akasaka M, Sato Y, Abe S, Totsuka Y, Tohji K (2009) Material nanosizing effect on living organism: non-specific, biointeractive, physical size effects. J R Soc Interf 6: 371-388.
91. Wiedenmann J, Schenk A, Röcker C, Girod A, Spindler KD, Nienhaus GU (2002) A far-red fluorescent protein with fast maturation and reduced oligomerization tendency from Entacmaea quadricolor (Anthozoa, Actinaria). Prod Natl Acad Sci USA 99: 11646-11651.
92. Wiedenmann J, Ivanchenko S, Oswald F, Nienhaus GU (2004) Identification of GFP-like proteins in nonbioluminescent, azooxanthellate anthozoa opens new perspectives for bioprospecting. Mar Biotechnol 6: 270-277.
93. Wiesner MR, Lowry GV, Alvarez P, Dionysiou D, Biswas P (2006) Assessing the risks of manufactured nanomaterials. Environ Sci Technol 40: 4336-4345.
94. Yan M, Du J, Gu Z, Liang M, Hu Y, Zhang W, Priceman S, Wu L, Hong Zhou Z, Liu H, Segura T, Tang Y, Lu Y (2009) A novel intracellular protein delivery platform based on single-protein nanocapsules. Nat Nanotechnol 5: 48-53.
95. Ye-Qin Z, Wang Y-F, Jiang X-D (2008) The application of nanoparticles in biochips. Recent Patents Biotechnol 2(1): 55-59.
96. Zhang J, Yan YB (2005) Probing conformational changes of proteins by quantitative second-derivative infrared spectroscopy. Anal Biochem 340: 89-98.
97. Zhou HS, Aoki S, Honma I, Hirasawa M, Nagamune T, Komiyama H (1997) Conformational change of protein cytochrome b-562 adsorbed on colloidal gold particles; absorption band shift. Chem Commun. 605-606.